TMEDLIO

LIVE

Serial Number

79382510

Owner

IO Biotech ApS

Attorney

Bryce J. Maynard

Filing Date

Sep 20, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

TMEDLIO Trademark

Serial Number: 79382510 • Registration: 7445424

TMEDLIO is a trademark filed by IO Biotech ApS on September 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

IO Biotech ApS (10 trademarks)

Ole Maaløes Vej 3

Entity Type: 99

Legal Representation

Attorney of Record

Bryce J. Maynard

506 trademarks filed View all →

Correspondence Address

Bryce J. Maynard Buchanan Ingersoll & Rooney PC

1737 King Street, Suite 500

Alexandria, VA 22314

UNITED STATES

Trademark Details

Filing Date

September 20, 2023

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Apr 19, 2025 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 31, 2025 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Mar 31, 2025 OPNR

FINAL DECISION TRANSACTION PROCESSED BY IB

Jan 17, 2025 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Dec 29, 2024 FICS

FINAL DISPOSITION PROCESSED

Dec 29, 2024 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 18, 2024 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 16, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 16, 2024 R.PR

REGISTERED-PRINCIPAL REGISTER

Jul 16, 2024 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 30, 2024 NPUB

PUBLISHED FOR OPPOSITION

Apr 30, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 10, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 26, 2024 CNSA

EXAMINER'S AMENDMENT ENTERED

Feb 5, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 5, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 5, 2024 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 5, 2024 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 25, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 24, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 24, 2024 TROA

REFUSAL PROCESSED BY IB

Jan 23, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 30, 2023 RFCS

REFUSAL PROCESSED BY MPU

Dec 30, 2023 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 20, 2023 RFCR

NON-FINAL ACTION WRITTEN

Dec 19, 2023 CNRT

ASSIGNED TO EXAMINER

Dec 18, 2023 DOCK

APPLICATION FILING RECEIPT MAILED

Nov 10, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 6, 2023 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 2, 2023 REPR

Related Trademarks

More from this Owner

CYLEMBIO

More in Same Class

THE FUTURE OF MEDICINE IS ACELLULAR BIOLOGICS

TONICITY SOLUTION